GPX3 and neoplasm: We confirmed that in several cancer types, including lung squamous cell carcinoma (LUSC), PRAD, KIRP, LUAD, BRCA, and COAD, the expression of GPX3 was significantly lower in tumor tissues (Figure 5A).